Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant

Summary

This is a two-part, open label, single-dose study that will evaluate the PK of tozadenant in subjects with different degrees of hepatic impairment to the PK of a single-dose of tozadenant in healthy subjects.

Timeline

Start

2017-06-30

Primary completion

2017-12-31

Completion

2017-12-31

Drugs

Indications

No indication recorded.